TY - JOUR AU - Naidoo, J. PY - 2016 DA - 2016// TI - Large cell Neuroendocrine carcinoma of the lung: Clinico-pathologic features, treatment, and outcomes JO - Clinical lung cancer VL - 17 UR - https://doi.org/10.1016/j.cllc.2016.01.003 DO - 10.1016/j.cllc.2016.01.003 ID - Naidoo2016 ER - TY - JOUR AU - Veronesi, G. PY - 2006 DA - 2006// TI - Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases JO - Lung Cancer VL - 53 UR - https://doi.org/10.1016/j.lungcan.2006.03.007 DO - 10.1016/j.lungcan.2006.03.007 ID - Veronesi2006 ER - TY - JOUR AU - Treut, J. PY - 2013 DA - 2013// TI - Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study JO - Ann Oncol : official J European Soc Med Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt009 DO - 10.1093/annonc/mdt009 ID - Treut2013 ER - TY - JOUR AU - Rekhtman, N. PY - 2016 DA - 2016// TI - Next-generation sequencing of pulmonary large cell Neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets JO - Clin Cancer Res : an Official J Am Assoc Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2946 DO - 10.1158/1078-0432.CCR-15-2946 ID - Rekhtman2016 ER - TY - JOUR AU - Miyoshi, T. PY - 2017 DA - 2017// TI - Genomic profiling of large-cell Neuroendocrine carcinoma of the lung JO - Clin Cancer Res : an Official J Am Assoc Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0355 DO - 10.1158/1078-0432.CCR-16-0355 ID - Miyoshi2017 ER - TY - STD TI - Chae YK, et al. Genomic alterations (GA) and tumor mutational burden (TMB) in large cell neuroendocrine carcinoma of lung (L-LCNEC) as compared to small cell lung carcinoma (SCLC) as assessed via comprehensive genomic profiling (CGP). J Clin Oncol 35, Abstr 8517; 2017. ID - ref6 ER - TY - JOUR AU - Antonia, S. J. PY - 2016 DA - 2016// TI - Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial JO - The Lancet Oncology VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30098-5 DO - 10.1016/S1470-2045(16)30098-5 ID - Antonia2016 ER - TY - JOUR AU - Kratz, J. R. PY - 2012 DA - 2012// TI - A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61941-7 DO - 10.1016/S0140-6736(11)61941-7 ID - Kratz2012 ER - TY - JOUR AU - Kratz, J. R. AU - Eeden, S. K. AU - He, J. AU - Jablons, D. M. AU - Mann, M. J. PY - 2012 DA - 2012// TI - A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors JO - JAMA VL - 308 UR - https://doi.org/10.1001/jama.2012.13551 DO - 10.1001/jama.2012.13551 ID - Kratz2012 ER - TY - JOUR AU - Fossella, F. PY - 2003 DA - 2003// TI - Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.12.046 DO - 10.1200/JCO.2003.12.046 ID - Fossella2003 ER - TY - JOUR AU - Kamboj, M. PY - 2015 DA - 2015// TI - Neuroendocrine carcinoma of gall bladder: a series of 19 cases with review of literature JO - J Gastrointestinal Cancer VL - 46 UR - https://doi.org/10.1007/s12029-015-9745-9 DO - 10.1007/s12029-015-9745-9 ID - Kamboj2015 ER - TY - JOUR AU - Liu, D. J. PY - 2017 DA - 2017// TI - Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas JO - World J Gastroenterol VL - 23 UR - https://doi.org/10.3748/wjg.v23.i3.516 DO - 10.3748/wjg.v23.i3.516 ID - Liu2017 ER - TY - JOUR AU - Ki, E. Y. AU - Park, J. S. AU - Lee, K. H. AU - Bae, S. N. AU - Hur, S. Y. PY - 2014 DA - 2014// TI - Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature JO - World J Surg Oncol VL - 12 UR - https://doi.org/10.1186/1477-7819-12-314 DO - 10.1186/1477-7819-12-314 ID - Ki2014 ER - TY - JOUR AU - Vora, M. AU - Lacour, R. A. AU - Black, D. R. AU - Turbat-Herrera, E. A. AU - Gu, X. PY - 2016 DA - 2016// TI - Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation JO - Arch Gynecol Obstet VL - 293 UR - https://doi.org/10.1007/s00404-015-3865-0 DO - 10.1007/s00404-015-3865-0 ID - Vora2016 ER - TY - JOUR AU - Inoue, Y. PY - 2016 DA - 2016// TI - Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8528 DO - 10.18632/oncotarget.8528 ID - Inoue2016 ER - TY - JOUR AU - Rizvi, N. A. PY - 2015 DA - 2015// TI - Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa1348 DO - 10.1126/science.aaa1348 ID - Rizvi2015 ER - TY - JOUR AU - Koyama, S. PY - 2016 DA - 2016// TI - STK11/LKB1 Deficiency promotes Neutrophil recruitment and Proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1439 DO - 10.1158/0008-5472.CAN-15-1439 ID - Koyama2016 ER - TY - JOUR AU - George, J. PY - 2017 DA - 2017// TI - Genomic amplification of CD274 (PD-L1) in small-cell lung cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1069 DO - 10.1158/1078-0432.CCR-16-1069 ID - George2017 ER - TY - JOUR AU - Ikeda, S. PY - 2016 DA - 2016// TI - PD-L1 is Upregulated by simultaneous amplification of the PD-L1 and JAK2 genes in non-small cell lung cancer JO - J Thoracic Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.09.010 DO - 10.1016/j.jtho.2015.09.010 ID - Ikeda2016 ER - TY - JOUR AU - Chang, Y. L. AU - Yang, C. Y. AU - Huang, Y. L. AU - Wu, C. T. AU - Yang, P. C. PY - 2017 DA - 2017// TI - High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers JO - Oncotarget VL - 8 ID - Chang2017 ER - TY - JOUR AU - Schultheis, A. M. PY - 2015 DA - 2015// TI - PD-L1 expression in small cell neuroendocrine carcinomas JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2014.12.006 DO - 10.1016/j.ejca.2014.12.006 ID - Schultheis2015 ER - TY - JOUR AU - Ishii, H. PY - 2015 DA - 2015// TI - Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer JO - J Thoracic Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000414 DO - 10.1097/JTO.0000000000000414 ID - Ishii2015 ER - TY - JOUR AU - Komiya, T. AU - Madan, R. PY - 2015 DA - 2015// TI - PD-L1 expression in small cell lung cancer JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.06.003 DO - 10.1016/j.ejca.2015.06.003 ID - Komiya2015 ER -